Amgen Surpasses Third Quarter Earnings Expectations, Raises Year-End Guidance
Daily NewsNEW YORK - Biotechnology giant Amgen (NASDAQ:AMGN) reported third-quarter earnings that exceeded analyst expectations, driven by strong product sales growth acros...
Read More